Literature DB >> 11124753

Serum lithium as a compliance marker for food and supplement intake.

N M de Roos1, J H de Vries, M B Katan.   

Abstract

BACKGROUND: Analyzing 24-h urine for lithium after consumption of lithium-tagged foods or supplements provides a validated compliance marker but is laborious.
OBJECTIVE: Most studies involve blood sampling; therefore, we tested whether serum lithium concentration could be used as a compliance marker.
DESIGN: We used serum lithium as a compliance marker in a dietary trial and an evaluation study.
RESULTS: In the dietary trial, 78 volunteers consumed 500 mL yogurt tagged with lithium (250 micromol/d) for 6 wk. Serum lithium increased from 0.9+/-0.3 to 6.6+/-1.5 micromol/L, which was close to the predicted concentration, indicating that the subjects were highly compliant. However, the interindividual variability in serum lithium concentration was large. To test whether this variability resulted from compliance differences or natural variability, we performed an evaluation study: 12 subjects took a lithium supplement (250 micromol/d) for 13 d under supervision. Serum lithium increased from 0.14+/-0.03 to 3.9+/-0.8 micromol/L (range: 2.6-5.4 micromol/L); thus, there was wide interindividual variation in serum lithium despite 100% compliance. However, within-subject variability was small, with a CV of 7% for serum lithium measured on 4 different days. We checked whether taking half the dose on each of 2 d (125 micromol lithium/d) would significantly lower serum lithium. Indeed, serum lithium dropped in all subjects, by a mean of 1.0 micromol/L on the first day (P<0.0001) and by another 0.3 micromol/L on the second day (P = 0.0004). Thus, changes in serum lithium concentration of > or =1.0 micromol/L suggest altered compliance.
CONCLUSION: Serum lithium concentrations after intake of lithium-tagged foods or supplements can be used to assess compliance in dietary trials.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11124753     DOI: 10.1093/ajcn/73.1.75

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  5 in total

1.  Comparison of methods to assess adherence to small-quantity lipid-based nutrient supplements (SQ-LNS) and dispersible tablets among young Burkinabé children participating in a community-based intervention trial.

Authors:  Souheila Abbeddou; Sonja Y Hess; Elizabeth Yakes Jimenez; Jérôme W Somé; Stephen A Vosti; Rosemonde M Guissou; Jean-Bosco Ouédraogo; Kenneth H Brown
Journal:  Matern Child Nutr       Date:  2015-12       Impact factor: 3.092

2.  The use of lithium as a marker for the retention of liquids in the oral cavity after rinsing.

Authors:  Sara M Hanning; Jules A Kieser; Martin M Ferguson; Malcolm Reid; Natalie J Medlicott
Journal:  Clin Oral Investig       Date:  2013-11-22       Impact factor: 3.573

3.  Adenosine 5'-triphosphate (ATP) supplements are not orally bioavailable: a randomized, placebo-controlled cross-over trial in healthy humans.

Authors:  Ilja Cw Arts; Erik Jcm Coolen; Martijn Jl Bours; Nathalie Huyghebaert; Martien A Cohen Stuart; Aalt Bast; Pieter C Dagnelie
Journal:  J Int Soc Sports Nutr       Date:  2012-04-17       Impact factor: 5.150

Review 4.  Towards a Unified Understanding of Lithium Action in Basic Biology and its Significance for Applied Biology.

Authors:  Eric Jakobsson; Orlando Argüello-Miranda; See-Wing Chiu; Zeeshan Fazal; James Kruczek; Santiago Nunez-Corrales; Sagar Pandit; Laura Pritchet
Journal:  J Membr Biol       Date:  2017-11-10       Impact factor: 1.843

5.  Evaluation of Saccharin and Resveratrol as Extrinsic Markers of Small-Quantity Lipid-Based Nutrient Supplement Consumption in Healthy Women.

Authors:  Sarah J Zyba; Valerie Weinborn; Charles D Arnold; Arlie L Lehmkuhler; Fanny B Morel; Mamane Zeilani; Alyson E Mitchell; Marjorie J Haskell
Journal:  Curr Dev Nutr       Date:  2021-07-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.